AstraZeneca - July 2022 - Case Study 38

Start date:

Supporting and optimising treatment of Asthma patients in a Severe Asthma setting by objectively measuring adherence through the introduction of Turbu+, a digital intervention

Last modified: 22 November 2023

Last reviewed: 22 November 2023